AI ‘liquid biopsies’ using cell-free DNA, protein biomarkers, could aid early detection of ovarian cancer
A blood test that uses artificial intelligence (AI) to detect cancer-related genetic changes and protein…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Researchers develop revolutionary technology to unravel complex protein interactions that could transform cancer diagnostics
A team of researchers from NUS Institute for Health Innovation & Technology (iHealthtech), led by Associate Professor…
Circular peptides in violets turbocharges chemotherapy for glioblastoma
Violets produce a dazzling suite of small circular peptides called cyclotides. They roughly appear in…
Trial supports radiotherapy and cisplatin should remain the standard of care for p16+ oropharyngeal cancer
The NRG Oncology NRG-HN005 phase II/III clinical trial did not meet the non-inferiority criteria to…
Trial implies the addition of atezolizumab concurrently to standard of care does not improve survival in limited-stage small cell lung cancer
The addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation…
Radon, even at levels below EPA guideline for mitigation, is linked to childhood leukaemia
A study of more than 700 counties across multiple U.S. states found a link between…
FDA approves amivantamab-vmjw with carboplatin and pemetrexed for non-small cell lung cancer with EGFR exon 19 deletions or L858R mutations
On September 19, 2024, the Food and Drug Administration approved amivantamab-vmjw with carboplatin and pemetrexed…
Most accurate ultrasound test could detect 96% of women with ovarian cancer
An ultrasound test that detected 96% of ovarian cancers in postmenopausal women should replace the…
Medical imaging breakthrough could transform cancer and arthritis diagnosis
A new hand-held scanner developed by UCL researchers can generate highly detailed 3D photoacoustic images…
Maybe we shouldn’t even call low-grade prostate cancer “cancer”
A new paper in the Journal of the National Cancer Institute, indicates that patients may benefit…